Organigram Global (OGI) Asset Writedowns and Impairment (2020 - 2026)
Organigram Global (OGI) reported Asset Writedowns and Impairment of $4.2 million for Q1 2026, up 428.67% quarter-over-quarter from $800000.0 in Q2 2021.
Organigram Global (OGI) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Organigram Global (OGI) has 3 years of Asset Writedowns and Impairment data on file, last reported at $4.2 million in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $4.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $32.5 million (changed N/A YoY), and the FY2023 annual result was $122.6 million, changed N/A from the prior year.
- Asset Writedowns and Impairment advanced to $4.2 million in Q1 2026 per OGI's latest filing, from $800000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $4.2 million in Q1 2026 and troughed at $4.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Mar 31, 2026 | 4.23 Mn |
| May 31, 2021 | 800,000.00 |
| May 31, 2021 | 800,000.00 |
| Feb 28, 2021 | 500,000.00 |
| Feb 28, 2021 | 500,000.00 |
| May 31, 2020 | 26.99 Mn |
| May 31, 2020 | 26.99 Mn |